Keywords: Dr Reddy's Russia, In-licening deals, Cipla, Vitabiotics

Dr Reddy’s expands portfolio in Russia and CIS via in-licensing deals with Cipla and Vitabiotics

Article | 26 October 2010

Print This

Hyderabad-based Dr Reddy’s Laboratories (DRL; NYSE: RDY), India’s second largest drugmaker, has entered into an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in